- Fragile X-associated Disorders
- Treatment & Intervention
- Support the NFXF
(Walnut Creek, CA, April 9, 2013) There continues to be exciting news of research advancements on the Fragile X gene and its links to autism. New research studies are discovering more pathways linking Fragile X and autism. In addition, bi-partisan support is growing in Congress to continue building on the success of the federally funded Fragile X research. Parents who have children enrolled in promising clinical drug trials around the country are raising awareness through social and traditional media as well as directly to their elected representatives. Later this spring, Congressman Greg Harper (R-MS) and the National Fragile X Foundation will host a Congressional Roundtable to explore how best to realize the full potential of these research breakthroughs linking Fragile X and autism. The White House clearly sees this potential as well, as the proposed $100 million brain mapping project will only accelerate the pace at which Fragile X and autism will be conquered. Members of the House of Representatives are also expected to introduce legislation later this month to reallocate up to $200 million from public funding of presidential elections and party conventions to NIH research.
Neuroscientists at MIT‘s Picower Institute for Learning and Memory report in the March 18 Proceedings of the National Academy of Sciences (PNAS) that they have reversed autism and fragile X symptoms in adult mice with a single dose of an experimental drug.
The work from the laboratory of Nobel laureate Susumu Tonegawa, the Picower Professor in the Department of Biology and a principal investigator at the Picower Institute, points to yet additional potential targets for drugs that may one day improve Fragile X and autism symptoms such as hyperactivity, repetitive behaviors and seizures by modifying molecular mechanisms underlying the disease.
“These findings suggest a possible novel therapeutic target for the treatment of fragile X syndrome (FXS) — the most common inherited form of autism and intellectual disability,” said Eric Klann, a professor of neural science at New York University. (via MIT.edu)
After nearly 200 parents of individuals living with Fragile X convened in Washington, DC on March 5-6 to advocate for continued funding and more efficient use of the dollars our federal government invests in research, the word is now spreading throughout the nation. Letters to the Editors have been published in Michigan, Illinois, Connecticut, Massachusetts, Louisiana, Colorado, Mississippi, Arizona, North Carolina, Utah and Kansas as families continue to spread the word about the closely related conditions of Fragile X and autism. Here’s one example from the Dearborn Press & Guide (MI)
To the Editor:
In the past year, ground-breaking research has uncovered precise genetic links between autism and fragile X syndrome giving families like ours hope that treatment for many of the core symptoms of both conditions is on the horizon. New drugs currently in clinical trials have been shown to have a significant effect on reducing the symptoms of severe social impairment in people with autism or fragile X syndrome. Many families in Michigan are participating in these exciting trials. Reducing repetitive behaviors and improving social skills would allow our family members to lead more independent lives.
While most people know about autism and autism spectrum disorders, not as many are aware of fragile X syndrome. Fragile X syndrome is closely related to autism, is the most common inherited cause of intellectual disabilities, and is the most common genetic cause of autism.
It is imperative that the advancements made through these ground-breaking research projects continue to be built upon. We have just returned from Washington, DC, where we met with members of Congress to raise awareness of Fragile X, this breakthrough research and its potential. Wise stewardship of federal research dollars would encourage continued investment and expand the scope of research into the links between Fragile X and autism.
The promise of this research gives hope to many of us in Michigan who have family members with autism and fragile X syndrome that independence and social acceptance are within reach in our lifetime.
Behaviorally, intellectually and neurologically the spectrum presentation of Fragile X and disorders on the autism spectrum overlap and intersect and research continues to expose the secrets of these closely related conditions. The Centers for Disease Control (CDC) recently found that incidences of autism spectrum disorders in school age children (ages 6-17) to now be at 2 percent, or 1 in 50, up from 1 in 86 (or 1.16 percent) in 2007 for the same age group. (via CDC.gov)
Although there is concern about the sheer number of individuals and families impacted, Fragile X and autism researchers are giving everyone hope for a brighter future.
The National Fragile X Foundation, founded in 1984, is a 501(c)(3) nonprofit organization that provides informational, referral and emotional support; educational and awareness materials and activities; support for research including the translation of science into new and improved treatments; and legislative advocacy. More information is available at www.fragilex.org.